Beckman Coulter Reagent Kit Access® Antibody Test SARS-CoV-2 IgM For use with Access Family of Im...
| Item Id | 1172371 |
| MF Id# | C58957 |
| Brand | Access® |
| Manufacturer | Beckman Coulter |
| Country of Origin | Ireland |
| Application | Reagent Kit |
| Container Type | Well |
| For Use With | For use with Access Family of Immunoassay Systems |
| Form | Liquid |
| Number of Tests | 200 Tests |
| Product Dating | McKesson Acceptable Dating: we will ship >= 90 days |
| Sample Type | Human Serum / Plasma Sample |
| Storage Requirements | Requires Refrigeration |
| Test Method | Two-step Immunocapture Immunoassay |
| Test Name | SARS-CoV-2 IgM |
| Test Type | Antibody Test |
| Time to Results | 37 Minute Results |
| UNSPSC Code | 41116144 |
Features
- The Access SARS-CoV-2 IgM Assay is only for use under the FDA's Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform moderate or high complexity tests
- Access SARS%XE2%X80?CoV%XE2%X80?2 IgM is a paramagnetic particle, chemiluminescent immunoassay intended for the qualitative detection of IgM antibodies to SARS%XE2%X80?CoV%XE2%X80?2 in human serum, serum separator tubes and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, sodium citrate)
- Access SARS%XE2%X80?CoV%XE2%X80?2 IgM is intended for use as an aid in identifying individuals with an adaptive immune response to SARS%XE2%X80?CoV%XE2%X80?2, indicating recent or prior infection; at this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity.
- Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
- The sensitivity of the Access SARS-CoV-2 IgM assay early after infection is unknown; negative results do not preclude acute SARS-CoV-2 infection
- False positive results for the Access SARS%XE2%X80?CoV%XE2%X80?2 IgM assay may occur due to cross%XE2%X80?reactivity from pre%XE2%X80?existing antibodies or other possible causes; due to the risk of false positive results, confirmation of positive results should be considered using a second different assay
- Time-to-first result (approx.): 37 minutes
- Sample volume: 10uL